Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer

The tumor microenvironment (TME) plays critical roles in immune modulation and malignancies the process of cancer development. Immune cells constitute a significant component TME influence migration metastasis cells. Recently, number therapeutic approaches targeting have proven promising already been used to treat different types cancer. In particular, PD-1 PD-L1 inhibitors first-line setting non-small cell lung (NSCLC) with expression ≥1%, as approved by FDA. this review, we provide an introduction their efficacies, then discuss current immunotherapies NSCLC scientific research progress field.